Epilepsy is a pathologic condition with high prevalence and devastating consequences for the patient and its entourage. Means for accurate diagnosis of type, patient monitoring for predicting seizures and follow up, and efficacious treatment are desperately needed. To improve this adverse outcome, miRNAs and the chaperone system (CS) are promising targets to understand pathogenic mechanisms and for developing theranostics applications. miRNAs implicated in conditions known or suspected to favor seizures such as neuroinflammation, to promote epileptic tolerance and neuronal survival, to regulate seizures, and others showing variations in expression levels related to seizures are promising candidates as useful biomarkers for diagnosis and patient monitoring, and as targets for developing novel therapies. Components of the CS are also promising as biomarkers and as therapeutic targets, since they participate in epileptogenic pathways and in cytoprotective mechanisms in various epileptogenic brain areas, even if what they do and how is not yet clear. The data in this review should help in the identification of molecular targets among the discussed miRNAs and CS components for research aiming at understanding epileptogenic mechanisms and, subsequently, develop means for predicting/preventing seizures and treating the disease.

Zummo L., Vitale A.M., Caruso Bavisotto C., De Curtis M., Garbelli R., Giallonardo A.T., et al. (2021). Molecular chaperones and mirnas in epilepsy: Pathogenic implications and therapeutic prospects [10.3390/ijms22168601].

Molecular chaperones and mirnas in epilepsy: Pathogenic implications and therapeutic prospects

Zummo L.;Vitale A. M.;Caruso Bavisotto C.;Cappello F.;Gammazza A. M.
2021-08-10

Abstract

Epilepsy is a pathologic condition with high prevalence and devastating consequences for the patient and its entourage. Means for accurate diagnosis of type, patient monitoring for predicting seizures and follow up, and efficacious treatment are desperately needed. To improve this adverse outcome, miRNAs and the chaperone system (CS) are promising targets to understand pathogenic mechanisms and for developing theranostics applications. miRNAs implicated in conditions known or suspected to favor seizures such as neuroinflammation, to promote epileptic tolerance and neuronal survival, to regulate seizures, and others showing variations in expression levels related to seizures are promising candidates as useful biomarkers for diagnosis and patient monitoring, and as targets for developing novel therapies. Components of the CS are also promising as biomarkers and as therapeutic targets, since they participate in epileptogenic pathways and in cytoprotective mechanisms in various epileptogenic brain areas, even if what they do and how is not yet clear. The data in this review should help in the identification of molecular targets among the discussed miRNAs and CS components for research aiming at understanding epileptogenic mechanisms and, subsequently, develop means for predicting/preventing seizures and treating the disease.
https://www.mdpi.com/1422-0067/22/16/8601
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395327/
Zummo L., Vitale A.M., Caruso Bavisotto C., De Curtis M., Garbelli R., Giallonardo A.T., et al. (2021). Molecular chaperones and mirnas in epilepsy: Pathogenic implications and therapeutic prospects [10.3390/ijms22168601].
File in questo prodotto:
File Dimensione Formato  
ijms-22-08601-compresso.pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 375 kB
Formato Adobe PDF
375 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/528320
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact